Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115773) titled 'Research on the Mechanism and Clinical Efficacy of Artificial IHDF in Regulating Hypertension during Hemodialysis' on Dec. 31, 2025.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Nanchang University First Affiliated Hospital Gaoxin Hospital
Condition:
Uremic stage of chronic renal failure
Intervention:
HD Group:In the first week, HD treatment was received, followed by a two-week elution period (i.e., recovery to conventional HD). In the fourth week, artificial IHDF treatment was received. At the end of the treatment, the blood index levels before and after dialysis were compare...